Imagine a world where viruses become even more formidable—not on Earth, but in the microgravity environment of the International Space Station (ISS). This isn’t science fiction; it’s a groundbreaking discovery that could reshape how we understand microbial behavior in space and on our planet. But here’s where it gets controversial: could this mean that space travelers face unseen threats from evolving microbes, or might it unlock revolutionary treatments for antibiotic-resistant infections back home? Let’s dive in.
The ISS is a unique, closed ecosystem where the rules of biology don’t always mirror those on Earth. To explore this, researchers from the University of Wisconsin-Madison conducted a fascinating study on bacteriophages—viruses that infect bacteria, often called phages—both on the ISS and on Earth. Their findings, published in PLOS Biology, reveal that microgravity can slow down infections, alter the evolutionary dance between phages and bacteria, and even uncover genetic mutations that could combat disease-causing bacteria on Earth.
But this is the part most people miss: Dr. Phil Huss, one of the study’s lead authors, emphasizes that this isn’t just astrobiology trivia. It’s a practical way to predict how microbes behave in spacecraft and to discover new solutions for phage therapy and microbiome engineering. As he puts it, ‘Studying phage-bacteria systems in space isn’t just a curiosity; it’s a gateway to innovations we can use right here on Earth.’
Bacteriophages: The Unseen Powerhouses
Bacteriophages, or phages, are the most abundant biological entities on Earth, with estimates reaching a staggering 10^31—that’s ten nonillion! These ‘eaters of bacteria’ are everywhere, from ocean depths to our own bodies. But their most exciting role might be as a weapon against antibiotic-resistant bacteria, a growing global health crisis.
Phages act like tiny, protein-wrapped delivery systems. Unlike a pizza delivery, though, some phages (like the T7 phage used in this study) attach to specific surface features on bacterial cells and inject their genetic material. Once inside, they hijack the bacteria’s machinery to replicate, eventually bursting the cell and releasing a new wave of phages. This triggers an evolutionary arms race, as bacteria evolve to resist these attacks by altering or hiding the phage’s ‘landing pad.’
A Virus-Bacteria Showdown in Orbit
To study microgravity’s impact, researchers pitted the T7 phage against Escherichia coli (E. coli) in identical experiments on the ISS and Earth. The challenge? Designing an experiment that meets NASA’s strict safety and logistical constraints, including sealed cryovials that can withstand freeze-thaw cycles and remain safe in orbit. ‘The sample size is much smaller than what we’re used to on Earth,’ Huss explains, ‘and that makes designing these experiments incredibly challenging.’
The team varied the starting ratios of phages to bacteria, ensuring some samples would infect quickly while others would show slower, more dynamic interactions. Because the experiments couldn’t run perfectly in parallel, they meticulously matched incubation times between the ISS and Earth—a common workaround for space-based biology.
Microgravity Slows the Game
On Earth, T7 phages can infect and kill E. coli in under an hour. But in microgravity, the process slowed significantly. While Earth-based samples showed a surge in infections between two and four hours, the ISS samples remained unchanged during shorter incubation periods. However, after 23 days in orbit, the phages successfully infected and reduced E. coli populations.
Why the slowdown? Huss hypothesizes that microgravity reduces fluid mixing, lowering the chances of phages and bacteria encountering each other. Additionally, microgravity-induced stress on bacteria may alter their receptor expression, making infection harder. In essence, microgravity delays the entire cycle, giving bacteria more time to evolve resistance.
Microgravity Mutations: A New Frontier
After 23 days, the team analyzed the phages’ genetic makeup and found microgravity-specific mutations, particularly in genes related to structure and host interaction. These mutations changed how the phages infected bacteria. ‘Microgravity pushed evolution into corners of the phage we still don’t fully understand,’ Huss notes.
The bacteria evolved too. E. coli exposed to phages accumulated more mutations than those without phage threats, consistent with the evolutionary arms race. Notably, changes in genes linked to outer membranes may have altered phage attachment while helping bacteria survive stress. ‘Microgravity doesn’t just slow things down,’ Huss explains, ‘it reshapes the entire coevolutionary process.’
Microgravity: A Game-Changer for Earth-Based Medicine?
Using deep mutational scanning, the team identified over 1,600 mutation variants in the phage genome. The ‘winning’ mutations in microgravity differed sharply from those on Earth, suggesting that microgravity reveals unique fitness landscapes. These mutations were used to create altered phages that successfully killed uropathogenic E. coli—strains linked to urinary tract infections.
‘Phage mutants enriched in microgravity could treat and kill resistant bacteria,’ says Dr. Srivatsan Raman, another lead author. ‘This tells us microgravity could be key to tackling pathogens on Earth.’
But there’s a catch. Conducting these experiments on the ISS is no small feat. ‘It takes years of planning and overcoming logistical challenges,’ Raman adds. ‘Routine execution would be incredibly difficult.’
The Future of Spaceflight and Beyond
These findings suggest that space microbes won’t remain static; they’ll adapt and evolve in microgravity-specific ways. Could this pose a threat to long-term space missions? ‘Microbes can adapt rapidly and in unexpected ways,’ Huss warns. ‘Future experiments should test if these adaptations include increased drug resistance or virulence.’
For Earth, the implications are more optimistic. Microgravity could help scientists develop phages to combat resistant bacteria, from salmonella to sepsis. ‘Space-derived fitness landscapes can merge with terrestrial data to sharpen therapeutic strategies,’ Huss concludes.
So, here’s the big question: As we venture further into space, should we be more concerned about evolving microbes, or should we focus on harnessing microgravity’s potential to revolutionize medicine? Let us know your thoughts in the comments—this debate is just getting started.
